Page last updated: 2024-11-03

proglumide and Cancer of Kidney

proglumide has been researched along with Cancer of Kidney in 1 studies

Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackmore, M1
Doherty, E1
Manning, JE1
Hirst, BH1

Other Studies

1 other study available for proglumide and Cancer of Kidney

ArticleYear
Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
    International journal of cancer, 1994, May-01, Volume: 57, Issue:3

    Topics: Benzamides; Benzodiazepinones; Cell Division; Devazepide; Gastrins; Humans; Indoles; Kidney Neoplasm

1994